Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04797403 · ClinicalTrials.gov registry record · NA

Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline

A NA study of Hypertension and Cognitive Decline, sponsored by Tulane University.

Active
Registry status
NA
Development phase
1,306
Enrollment target
1
Study location

NCT04797403 is a NA study of Hypertension and Cognitive Decline that is active but no longer recruiting, run by Tulane University. The registered enrollment target is 1,306 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04797403, a NA study of Hypertension and Cognitive Decline, is active but no longer recruiting, sponsored by Tulane University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,306 participants
Enrollment target
1
Study location

Study Summary

The study will test a multifaceted strategy for implementing an intensive blood pressure intervention protocol targeting systolic BP \<120 mmHg on cognitive decline in racial minority and low-income hypertensive patients in primary care. The proposed study will generate urgently needed data on effective, adoptable, and equitable intervention strategies to reduce blood pressure-related cognitive decline in low- income and minority populations. If proven effective, the implementation strategy for intensive blood pressure reduction could be adapted and scaled up in diverse primary care settings to prevent cognitive decline and clinical dementia.

Interventions

  • BEHAVIORAL Stepped-care protocol adapted from the SPRINT intensive-treatment algorithm

Study Locations (1)

Louisiana

  • Tulane University - New Orleans

Trial Details

FieldValue
Enrollment Target 1,306 participants
Start Date 2019-10-22
Est. Completion 2026-08
Phase NA

Sponsor

Tulane University

73 total trials

What the Registry Record Tells You About NCT04797403

The ClinicalTrials.gov registry entry for NCT04797403 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,306 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (63% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Stepped-care protocol adapted from the SPRINT intensive-treatment algorithm is the first listed.

NCT04797403 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT04797403 about?

NCT04797403 is a clinical study titled "Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline". The study will test a multifaceted strategy for implementing an intensive blood pressure intervention protocol targeting systolic BP \<120 mmHg on cognitive decline in racial minority and low-income hypertensive patients in primary care. The proposed study will generate urgently needed data on effec...

What is the current status of trial NCT04797403?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,306 participants. The study started on 2019-10-22. Estimated completion is 2026-08.

What conditions does trial NCT04797403 study?

This clinical trial studies the following conditions: Hypertension, Cognitive Decline.

What interventions are being tested in trial NCT04797403?

The interventions under investigation include: Stepped-care protocol adapted from the SPRINT intensive-treatment algorithm (BEHAVIORAL).

Who is sponsoring clinical trial NCT04797403?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04797403 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.